Peter Lüdike

Peter Lüdike

Interventional cardiologist / Cardiologist
Marienhospital Osnabrück - Onsabrück, Germany

Latest contributions

How to identify patients for tricuspid interventions

14 Dec 2023

Watch the replay of this webinar with J. Hausleiter, P. Lüdike, M. Adamo, N. Karam and N. Wunderlich to know more about the clinical presentation and medical therapy of patients with tricuspid regurgitation and much more!

Advanced imaging for structural interventions

21 Nov 2023 – From PCR London Valves 2023

Learn more about advanced imaging in structural interventions with this session: explore the utility of image fusion in guiding repeat TAVR for THV dysfunction, witness the precision of solo four-dimensional intracardiac echocardiography guiding TEER for tricuspid regurgitation, delve into the peri-procedural use of IVUS during bicaval...

Advanced imaging for structural interventions

How PASCAL Precision system can contribute to optimal TEER procedures

06 Dec 2023 – From PCR London Valves 2023

Join Peter Lüdike and Maurizio Taramasso as they discuss the key device-related issues for an optimal TEER procedure and how the latest generation of Pascal Precision system fits these needs.

This interview was filmed at PCR London Valves 2023: see more videos here.

How PASCAL Precision system can contribute to optimal TEER procedures

The EVOQUE and PASCAL Precision systems in action: simulation- and case-based learning

20 Nov 2023 – From PCR London Valves 2023

This session explores the features of the PASCAL Precision and the EVOQUE tricuspid replacement systems through simulators and case presentations, while a panel of experts discuss the technology, witnessing live demonstrations of treating mitral and tricuspid regurgitation patients.

Rapid-fire - Challenging tricuspid procedures

19 Nov 2023 – From PCR London Valves 2023

Discover challenging tricuspid procedures in this session: learn more about the struggle of recurrent heart failure in the presence of a left ventricular assist device, gain insights into single-stage percutaneous replacement of native pulmonary and tricuspid valves, navigate the complexities of managing bioprosthetic tricuspid stenosis post-cardiac...

Rapid-fire - Challenging tricuspid procedures

The new PASCAL Precision system unleashes the full potential of mitral transcatheter edge-to-edge repair

28 Nov 2022 – From PCR London Valves 2022

Join this panel of experienced physicians to learn more about the novel PASCAL Precision system and to discuss implant selection and clinical data. Finally, participate in a recorded case demonstrating the use of the PASCAL Precision system for the treatment of mitral regurgitation.

2022: a tipping point in the treatment of mitral regurgitation patients

17 May 2022 – From EuroPCR 2022

With study outcomes and clinical cases, this EuroPCR 2022 session will enable you to discuss the anatomical considerations that define suitable candidates for treatment of mitral regurgitation with the PASCAL platform and highlight key differentiators and tips and tricks for its use.

2022: a tipping point in the treatment of mitral regurgitation patients

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

23 Nov 2021 – From PCR London Valves

Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis

21 Nov 2021 – From PCR London Valves 2021

Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.

Outcomes following transcatheter and percutaneous mitral valve repair

21 Nov 2021 – From PCR London Valves 2021

CLASP study, predictability of post-delivery residual mitral regurgitation, MiCLASP PMCF study, off-pump transapical neochord implantation, pronostic impact of nutritional status, and patients with low, intermediate and high frailty are the focus of this session from PCR LV 2021 devoted to percutaneous and transcatheter mitral valve repair.

Outcomes following transcatheter and percutaneous mitral valve repair

The PASCAL platform: successfully and confidently treating MR

18 May 2021 – From EuroPCR 2021

Watch this session presented by Nicolas van Mieghem, Fabien Praz and Peter Lüdike in order to learn about the PASCAL platform and its differentiated features, to discuss how to identify patients for the treatment with the PASCAL platform, and to review clinical data and discuss patient outcomes...

The PASCAL platform: successfully and confidently treating MR

Embrace the future of mitral and tricuspid repair and replacement

18 May 2021 – From EuroPCR 2021

Watch this session presented by Stephan Baldus, Georg Nickenig, Philipp Lurz Physician, Maurizio Taramasso, Dabit Arzamendi, Jorg Hausleite, Peter Ludike, Roman Pfister and Philip Raake in order to learn about the Edwards repair and replacement transcatheter portfolio, to understand how to treat with transcatheter repair and replacement technologies the...

Embrace the future of mitral and tricuspid repair and replacement

Advancing mitral and tricuspid repair with the PASCAL repair system platform

23 Nov 2020 – From PCR Valves e-Course 2020

Watch this session if you want to uncover clinical impact of PASCAL repair system platform for MR and TR treatment, to see a recorded case using PASCAL Ace in MR and to discover the potential of transcatheter repair for the treatment of TR.

Advancing mitral and tricuspid repair with the PASCAL repair system platform